2Groeben H, Mitzner W, Brown R H. Effects of the 2 adre noceptor agonist dexmedetomidine on bronchoconstriction in dogs[J]. Anesthesiology, 2004,100(2), 359-363.
3Ramsay M A, Savege T M, Simpson B R J, et al. Controlled sedation with alphaxalonealphadolone[J]. Br Med J,1974,2 (5920) :656- 659.
4Rat M R,Parry T M,Dombrovskis A,etal. Remifentanil tar get-controlled infusion z's propofol target controlled infusion for conscious sedation for awake fibreoptic intubation: a doub le-blinded randomized controlled trial[J]. Br J Anaesth, 2008, 100(1) :125 -130.
5Cafiero T, Esposito F, Fraioli G, et al. Remifentanil TCI and propofol-TCI for conscious sedation during fibreoptic intuba tion in the acromegalic patient[JT. Eur J Anaesthesiol,2008, 25(8), 670-674.
6Jiang H, Sun Y, Zhu Y. A useful device for difficult nasal tra- cheal intubation in China[J]. Eur J Anaesthesiol, 2009,26 (7) : 621- 622.
7Eloor B C,Ward D S,Belleville J P,et al. Effects of intravenous dexmedetomidine in humans. . Hemodynamic changes[J]. Anesthesiology, 1992, 77(6) : 1134-1142.
8Belleville J P,Ward D S,Bloor B C,etal. Effects of intrave nous dexmedetomidine in humans. I. Sedation, ventilation, and metabolic rate[J]. Anesthesiology, 1992,77(6) : 1125- 1133.
9Hsu Y W,Cortinez L I, Robertson K M,et al. Dexmedetomi dine pharmacodynamies: Part : crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers[J]. Anesthesiology, 2004,101 ( 5 ) : 1066-1076.
10Rancourt MP,Albert NT,Cote M,et al.Posterior tibial nerve sensory blockade duration prolonged by adding dexmedetomidine to ropivacaine.Anesth Analg,2012,115(4):958-962.
